Literature DB >> 16099787

Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease.

J N Gordon1, T T MacDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16099787      PMCID： PMC1774677          DOI： 10.1136/gut.2004.063412

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  11 in total

Review 1.  Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks.

Authors:  A W O'Regan; G J Nau; G L Chupp; J S Berman
Journal:  Immunol Today       Date:  2000-10

2.  Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum.

Authors:  N Gassler; F Autschbach; S Gauer; J Bohn; B Sido; H F Otto; H Geiger; N Obermüller
Journal:  Scand J Gastroenterol       Date:  2002-11       Impact factor: 2.423

3.  T-bet and mucosal Th1 responses in the gastrointestinal tract.

Authors:  B Weigmann; M F Neurath
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

4.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.

Authors:  A Sturm; A Z A Leite; S Danese; K A Krivacic; G A West; S Mohr; J W Jacobberger; C Fiocchi
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 5.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

Authors:  Giorgio Trinchieri; Stefan Pflanz; Robert A Kastelein
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

Review 6.  Immunity, inflammation, and allergy in the gut.

Authors:  Thomas T Macdonald; Giovanni Monteleone
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 7.  IL-12 and Th1 immune responses in human Peyer's patches.

Authors:  T T MacDonald; G Monteleone
Journal:  Trends Immunol       Date:  2001-05       Impact factor: 16.687

Review 8.  Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC.

Authors:  Jaro Sodek; Baoqian Zhu; My-Hang Huynh; Theodore J Brown; Maurice Ringuette
Journal:  Connect Tissue Res       Date:  2002       Impact factor: 3.417

9.  Anti-interleukin-12 antibody for active Crohn's disease.

Authors:  Peter J Mannon; Ivan J Fuss; Lloyd Mayer; Charles O Elson; William J Sandborn; Daniel Present; Ben Dolin; Nancy Goodman; Catherine Groden; Ronald L Hornung; Martha Quezado; Zhiqiong Yang; Markus F Neurath; Jochen Salfeld; Geertruida M Veldman; Ullrich Schwertschlag; Warren Strober
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

10.  Distinct gene expression of osteopontin in patients with ulcerative colitis.

Authors:  Hideki Masuda; Yasuo Takahashi; Satoshi Asai; Tadatoshi Takayama
Journal:  J Surg Res       Date:  2003-05-01       Impact factor: 2.192
View more
  5 in total

1.  Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery.

Authors:  Manuela G Neuman
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

2.  Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions.

Authors:  Eytan Wine; Grace Shen-Tu; Mélanie G Gareau; Harvey A Goldberg; Christoph Licht; Bo-Yee Ngan; Esben S Sorensen; James Greenaway; Jaro Sodek; Ron Zohar; Philip M Sherman
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 3.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

4.  The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.

Authors:  Jürgen Glas; Julia Seiderer; Corinna Bayrle; Martin Wetzke; Christoph Fries; Cornelia Tillack; Torsten Olszak; Florian Beigel; Christian Steib; Matthias Friedrich; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

Review 5.  Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Nausicaa Clemente; Davide Raineri; Giuseppe Cappellano; Elena Boggio; Francesco Favero; Maria Felicia Soluri; Chiara Dianzani; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-12-20       Impact factor: 4.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.